CIK 0001645460
- Non-accelerated filer
- Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473324577
- Phone
- +1 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-09 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2025-12-03 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2025-09-26 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-03-21 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-06-05 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-03-06 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2023-07-21 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2023-02-16 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-03-25 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +16,667 | 16,667 | ||
| 2022-02-09 | Sandercock Colin SVP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-02-10 | Sandercock Colin SVP, General Counsel and Sec | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Option exercise | +13,374 | $7.50 | $100K | 30,499 |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Sale | −13,374 | $20.00 | $267K | 17,125 |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Option exercise · Stock Option (right to buy) | −13,374 | 130,000 | ||
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Option exercise | +13,274 | $7.50 | $100K | 30,399 |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Sale | −13,274 | $20.00 | $265K | 17,125 |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Option exercise · Stock Option (right to buy) | −13,274 | 130,100 | ||
| 2020-08-04 | Sandercock Colin SVP, General Counsel and Sec | Option exercise | +201 | $7.50 | $2K | 17,326 |
| 2020-08-04 | Sandercock Colin SVP, General Counsel and Sec | Sale | −201 | $20.05 | $4K | 17,125 |
| 2020-08-04 | Sandercock Colin SVP, General Counsel and Sec | Option exercise · Stock Option (right to buy) | −201 | 143,374 |
Page 1 of 2 · 31 trades